BIOFORCE NANOSCIENCES HOLDINGS INC. (BFNH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BFNH Annual Balance Sheets →
Balance sheet data covering BIOFORCE NANOSCIENCES HOLDINGS INC.–Jun 30 2025 offers a view into how Jun 30 2026's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Prepaid Expense, Current AS2.15
Total Current Assets2.15
Other Assets, Noncurrent0.23
Total Assets2.39
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.01
Accrued Salaries0.02
Other Liabilities, Current0.05
Total Current Liabilities0.08
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities0.08
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock162.06
Retained Earnings / Accumulated Deficit-162.28
Common Stockholder's Equity2.30
Total Stockholder's Equity2.30
Liabilities & Stockholder's Equity2.39
4 historic quarters locked

Sign in to unlock the full BIOFORCE NANOSCIENCES HOLDINGS INC. balance sheet history.

About Bioforce Nanosciences Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001091818-26-000108

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.